Physitrack (Q4 Review): Strategic reset complete; pivot to pure-SaaS growth acceleration - Redeye

Redeye has updated its estimates and valuation following Physitrack’s Q4 2025 report. While quarterly growth stalled, the Group's structural transformation into a "leaner, meaner" SaaS business is largely complete. We expect the Lifecare division—now representing c85% of Group-reported revenue—to remain the primary profit engine in the near term as the Wellness division enters a rebuilding phase after significant restructuring.

Länk till analysen i sin helhet: https://www.redeye.se/research/1155234/physitrack-q4-review-strategic-reset-complete-pivot-to-pure-saas-growth-acceleration?utm_source=finwire&utm_medium=RSS